Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery

Anesthesiology

Volumn 84, Issue 4, 1996, Pages 789-800

  Licker, Marc ^a   Neidhart, Peter ^b   Lustenberger, Sheila ^b   Valloton, Michael B ^c   Kalonji, Tshibambula ^d   Fathi, Marc ^e   Morel, Denis R ^a,f  

^a Div Anesthesiological I   (Switzerland)

^b Armed Forces Taoyuan General Hospitl   (Taiwan)

^c Division of Endocrinology   (United States)

^d Clinics of Cardiovascular Surgery

^e Laboratory of Clinical Chemistry   (Japan)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Hormones: renin angiotensin system; Pharmacology: angiotensin converting enzyme inhibitors; Surgery: cardiac; cardiopulmonary bypass; Sympathetic nervous system: catecholamines; epinephrine; norepinephrine

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADRENERGIC ACTIVITY; ADULT; AGED; ANESTHESIA INDUCTION; ARTERIAL OXYGEN TENSION; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY HEMODYNAMICS; DRUG EFFECT; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; LONG TERM CARE; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASCULAR RESISTANCE;

ADULT; AGED; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC SURGICAL PROCEDURES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; RENIN;

EID: 0029867538     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199604000-00005     Document Type: Article

References (47)

1. The 1988 Joint National Committee. The 1988 report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1988; 148:1023-38
2. The Consensus Trial Study Group: Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316: 1429-35
3. Rendina V, Iaccarino G, Russo R, EneaJ, Marchegiano R, Lembo G, Trimarco B: Trandalopril in patients with essential hypertension: Effects on vascular and cardiac structural changes. J Cardiovasc Pharmacol 1994; 23(suppl 1):S20-4
4. Lever AF, Lyall F, Morton JJ, Folkow B: Angiotensin II, vascular structure and blood pressure. Kidney Int Suppl 1992; 37:S51-5
5. Zerbe RL, Feuerstein G, Kopin IJ: Effect of captopril on cardiovascular, sympathetic and vasopressin responses to hemorrhage. Eur J Pharmacol 1981; 72:391-5
6. Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B: Effect of angiotensin-converting enzyme inhibition on blood pressure and renal function during open heart surgery. ANESTHESIOLOGY 1990; 72:23-7
7. Yates AP, Hunter DN: Anaesthesia and angiotensin-converting enzyme inhibitors. The effect of enalapril on peri-operative cardiovascular stability. Anaesthesia 1988; 43:935-8
8. Colson P, Grolleau D, Chaptal PA, Ribstein J, Mimran A, Roquefeuil B: Effect of preoperative renin-angiotensin system blockade on hypertension following coronary surgery. Chest 1988; 93:1156-8
9. Kataja JH, Kaukinen S, Viinamaki OV, Metsa-Ketela TJ, Vapaatalo H: Hemodynamic and hormonal changes in patients pretreated with captopril for surgery of the abdominal aorta. J Cardiothorac Anesth 1989; 3:425-32
10. Colson P, Saussine M, Séguin JR, Cuchet D, Chaptal PA, Roquefeuil B: Hemodynamic effects of anesthesia in patients chronically treated with angiotensin-converting enzyme inhibitors. Anesth Analg 1992; 74:805-8
11. Coriat P, Richer C, Douraki T, Gomez C, Hendricks K, Giudicelli J-F, Viars P: Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. ANESTHESIOLOGY 1994; 81: 299-307
12. Thaker U, Geary V, Chalmers P, Sheikh F: Low systemic vascular resistance during cardiac surgery: Case reports, brief review, and management with angiotensin II. J Cardiothorac Anesth 1990; 4:360-3
13. Fouad FM, Tarazi RC: Restoration of cardiac function and structure by converting enzyme inhibition, possibilities and limitations of long-term treatment in hypertension and heart failure. J Cardiovasc Pharmacol 1986; 8(suppl 1):S53-7
14. Grum DF, Azmy SS: Effect of chronic nifedipine therapy on the haemodynamic response to phenylephrine before and during halothane anaesthesia. Eur J Anaesthesiol 1992; 9:35-41
15. Haber E, Koerner T, Page LB, Kliman B, Purnode A: Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 1969; 29:1349-55
16. Gavras H, Hatzinikolaou P, North WG, Bresnahan M, Gavras I. Interaction of the sympathetic nervous system with vasopressin and renin in the maintenance of blood pressure. Hypertension 1982; 4:400-5
17. Brand PH, Metting PJ, Britton SL: Support of arterial blood pressure by major pressure control systems in conscious dogs. Am J Physiol 1988; 255(Heart Circ Physiol):H483-91
18. Waeber B, Nussberger J, Juillerat L, Brunner HR: Angiotensin-converting enzyme inhibition: Discrepancy between antihypertensive effect and suppression of enzyme activity. J Cardiovasc Pharmacol 1989; 14(suppl 4):S53-9
19. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H: Antihypertensive therapy with MK-421: Angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982; 4:966-72
20. Jackson B, Cubela R, Johnston CI: Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension. J Hypertens 1984; 2:371-7
21. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, Dzau VJ: Feedback regulation of angiotensin-converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993; 72: 312-8
22. Unger T, Gohlke P, Ganten D, Lang RE: Converting enzyme inhibitors and their effects on the renin-angiotensin system of the blood vessel wall. J Cardiovasc Pharmacol 1989; 13(suppl 3):S8-S16
23. Busse R, Fleming I, Hecker M: Endothelium-derived bradykinin: Implications for angiotensin-converting enzyme inhibitor therapy. J Cardiovasc Pharmacol 1993; 22(suppl 5):S31-6
24. Cody RJ Jr, Bravo EL, Fouad FM, Tarazi RC: Cardiovascular reflexes during long-term converting enzyme inhibition and sodium depletion. The response to tilt in hypertensive patients. Am J Med 1981; 71:422-6
25. Morioka S, Simon G, Cohn JN: Cardiac and hormonal effects of enalapril in hypertension. Clin Pharmacol Ther 1983; 34:583-9
26. Giudicelli JF, Berdeaux A, Edouard A, Richer C, Jacolot D: The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol 1985; 20:211-8
27. Niarchos AP, Pickering TG, Morganti A, Laragh JH: Plasma catecholamines and cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man. Clin Exp Hypertens 1982; 4:761-89
28. Dominiak P: Modulation of sympathetic control by ACE inhibitors. Eur Heart J 1993; 14(suppl 1):S169-72
29. Di Nardo JA, Bert A, Schwartz MJ, Johnson RG, Thurer RL, Weintraub RM: Effects of vasoactive drugs on flows through left internal mammary artery and saphenous vein graft in man. J Thorac Cardiovasc Surg 1991; 102:730-5
30. 1-Adrenergic responsiveness during coronary artery bypass surgery: Effect of preoperative ejection fraction. ANESTHESIOLOGY 1988; 69:206-17
31. Gillis CN, Pitt BR: The fate of circulatory amines within the pulmonary circulation. Ann Rev Physiol 1982; 44:269-81
32. Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovitch AD: Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995; 80:473-9
33. Okuno T, Kondo K, Konishi K, Saruta T, Kato E: SQ14,225 attenuates the vascular response to norepinephrine in the rat mesenteric arteries. Life Sci 1979; 25:1343-9
34. Schölkens BA, Xiang JZ, Tilly H: Influence of the converting enzyme inhibitors Hoe 498, enalapril, and captopril on vascular reactivity of isolated arterial preparations. Clin Exp Hypertens 1984; 1807-13
35. Fruncillo RJ, Rotmensch HH, Vlasses PH, Koplin JR, Swanson BN, Ferguson RK: Effect of Captopril and hydrochlorothiazide on the response to pressor agents in hypertensives. Eur J Clin Pharmacol 1985; 28:5-9
36. Imai Y, Abe K, Seino M, Haruyama T, Tajima J, Sato M, Goto T, Hiwatari M, Kasai Y, Yoshinaga K, Sekino H: Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects. Hypertension 1982; 4:444-51
37. Dzau VJ, Safar ME: Large conduit arteries in hypertension: Role of the vascular renin-angiotensin system. Circulation 1988; 77:947-54
38. Folkow B, Karlström G: Age- and pressure-dependent changes of systemic resistance vessels concerning the relationships between geometric design, wall distensibility, vascular reactivity and smooth muscle sensitivity. Acta Physiol Scand 1984; 122:17-33
39. Dzau VJ: Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 1993; 22(suppl 5):S1-9
40. Bockman CS, Jeffries WB, Abel PW: Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J Pharmacol Exp Ther 1993; 267:1126-33
41. Calver A, CollierJ, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: The nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10:1025-31
42. Tarnow J, Komar K: Altered hemodynamic response to dobutamine in relation to the degree of preoperative β-adrenoceptor blockade. ANESTHESIOLOGY 1988; 68:912-9
43. Grant RP, Jenkins LC: Modification by preoperative beta-blockade of the renin response to infrarenal aortic cross-clamping. Can Anaesth Soc J 1983; 30:480-6
44. Grum DF, Azmy SS: Does propranolol alter the vascular response to phenylephrine before or during halothane anaesthesia in patients with coronary artery disease? Can J Anaesth 1992; 39:41-6
45. Nayler WG: Pharmacological aspects of calcium antagonism. Short term and long term benefits. Drugs 1993; 46(suppl 2):40-7
46. Niarchos AP, Roberts AJ, Case DB, Gay WA Jr, Laragh JH. Hemodynamic characteristics of hypertension after coronary bypass surgery and effects of the converting enzyme inhibitor. Am J Cardiol 1979; 43:586-93
47. Perondi R, Saino A, Tio RA, Pomidossi G, Gregorini L, Alessio P, Morganti A, Zanchetti A, Mancia G: ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation 1992; 85:2004-13